Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.

Saved in:
Bibliographic Details
Title: Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
Authors: Saad, Fred1 (AUTHOR) fredsaad@videotron.ca, George, Daniel J.2 (AUTHOR) daniel.george@duke.edu, Cookson, Michael S.3 (AUTHOR) michael-cookson@ouhsc.edu, Saltzstein, Daniel R.4 (AUTHOR) daniel.saltzstein@urologysa.com, Tutrone, Ronald5 (AUTHOR) rtutrone@uniteduro.com, Bossi, Alberto6 (AUTHOR) alberto.bossi@gustaveroussy.fr, Brown, Bruce7 (AUTHOR) brucebrown91@gmail.com, Selby, Bryan7 (AUTHOR) bds_mv@yahoo.com, Lu, Sophia7 (AUTHOR), Tombal, Bertrand8 (AUTHOR) bertrand.tombal@saintluc.uclouvain.be, Shore, Neal D.9 (AUTHOR) nshore@auclinics.com
Source: Cancers. Oct2023, Vol. 15 Issue 19, p4854. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first